Bibliometric Analysis of the Relationship between Gut Microbiota and Chronic Kidney Disease from 2001-2022

被引:11
作者
Tao, Pengyu [1 ]
Huo, Jinlin [2 ]
Chen, Ling [1 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Peoples Hosp 7, Dept Nephrol, 358 Datong Rd, Shanghai 200137, Peoples R China
[2] Shantou Univ, Affiliated Hosp 1, Med Coll, Shantou 515041, Peoples R China
来源
INTEGRATIVE MEDICINE IN NEPHROLOGY AND ANDROLOGY | 2024年 / 11卷 / 01期
关键词
Gut microbiota; chronic kidney disease; bibliometric analysis; Web of Science Core Collection; VOSviewer; CiteSpace;
D O I
10.1097/IMNA-D-23-00017
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Background:The gut microbiota is closely associated with chronic kidney disease (CKD) development and prognosis. However, a comprehensive understanding of publication trends and research focuses within this domain remains limited. This study aimed to elucidate the relationship between the gut microbiota and CKD through a bibliometric analysis.Methods:Literature published between 2001 and 2022 on gut microbiota and CKD was obtained from the Web of Science Core Collection database. Bibliometric analysis tools such as VOSviewer and CiteSpace were used to analyze research trends in this area.Results:We extracted 758 articles for further analysis. China ranked first with 240 published documents, followed by the USA with 211. However, the USA ranked first regarding citation frequency with 11,380 citations, while China ranked second. The University of California Irvine and Kidney International emerged as the leading institution and journal, respectively, with the former leading in document production and citations. Although Kidney International featured fewer documents than other journals, it exhibited the highest citation count. The keywords representing the research interests mainly included: (1) gut microbiota influences the development of CKD, (2) application of probiotics in the treatment of CKD, and (3) potential mechanism of gut microbiota in CKD.Conclusion:Our analysis indicates significant advancements in understanding the association between gut microbiota and CKD. It also provides a comprehensive overview of publication trends, research hotspots, and frontiers, which may provide guidelines for future research.
引用
收藏
页数:9
相关论文
共 52 条
[1]   Intestinal Dysbiosis, Barrier Dysfunction, and Bacterial Translocation Account for CKD-Related Systemic Inflammation [J].
Andersen, Kirstin ;
Kesper, Marie Sophie ;
Marschner, Julian A. ;
Konrad, Lukas ;
Ryu, Mi ;
Kumar, Santhosh V. R. ;
Kulkarni, Onkar P. ;
Mulay, Shrikant R. ;
Romoli, Simone ;
Demleitner, Jana ;
Schiller, Patrick ;
Dietrich, Alexander ;
Mueller, Susanna ;
Gross, Oliver ;
Ruscheweyh, Hans-Joachim ;
Huson, Daniel H. ;
Stecher, Baerbel ;
Anders, Hans-Joachim .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 28 (01) :76-83
[2]   Chronic Kidney Disease - Another Step Forward [J].
August, Phyllis .
NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (02) :179-180
[3]   Exercise and chronic kidney disease: potential mechanisms underlying the physiological benefits [J].
Bishop, Nicolette C. ;
Burton, James O. ;
Graham-Brown, Matthew P. M. ;
Stensel, David J. ;
Viana, Joao L. ;
Watson, Emma L. .
NATURE REVIEWS NEPHROLOGY, 2023, 19 (04) :244-256
[4]   Chuan Huang Fang combining reduced glutathione in treating acute kidney injury (grades 1-2) on chronic kidney disease (stages 2-4): A multicenter randomized controlled clinical trial [J].
Chen, Ling ;
Ye, Zi ;
Wang, Danjun ;
Liu, Jianlian ;
Wang, Qian ;
Wang, Chen ;
Xu, Bing ;
Gong, Xuezhong .
FRONTIERS IN PHARMACOLOGY, 2022, 13
[5]   Efficacy and Safety of Chuan Huang Fang Combining Reduced Glutathione in Treating Acute Kidney Injury (Grades 1-2) on Chronic Kidney Disease (Stages 2-4): Study Protocol for a Multicenter Randomized Controlled Clinical Trial [J].
Chen, Ling ;
Gong, Xuezhong .
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
[6]   Microbiome-metabolome reveals the contribution of gut-kidney axis on kidney disease [J].
Chen, Yuan-Yuan ;
Chen, Dan-Qian ;
Chen, Lin ;
Liu, Jing-Ru ;
Vaziri, Nosratola D. ;
Guo, Yan ;
Zhao, Ying-Yong .
JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17 (1)
[7]   MMP-2 and 9 in Chronic Kidney Disease [J].
Cheng, Zhengyuan ;
Limbu, Manoj Hang ;
Wang, Zhi ;
Liu, Jing ;
Liu, Lei ;
Zhang, Xiaoyi ;
Chen, Pingsheng ;
Liu, Bicheng .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (04)
[8]   Microbiota issue in CKD: how promising are gut-targeted approaches? [J].
Cosola, Carmela ;
Rocchetti, Maria Teresa ;
Sabatino, Alice ;
Fiaccadori, Enrico ;
Di Iorio, Biagio Raffaele ;
Gesualdo, Loreto .
JOURNAL OF NEPHROLOGY, 2019, 32 (01) :27-37
[9]   The Role of Gut Dysbiosis in the Bone-Vascular Axis in Chronic Kidney Disease [J].
Evenepoel, Pieter ;
Dejongh, Sander ;
Verbeke, Kristin ;
Meijers, Bjorn .
TOXINS, 2020, 12 (05)
[10]   Phosphate, Microbiota and CKD [J].
Favero, Chiara ;
Carriazo, Sol ;
Cuarental, Leticia ;
Fernandez-Prado, Raul ;
Goma-Garces, Elena ;
Vanessa Perez-Gomez, Maria ;
Ortiz, Alberto ;
Fernandez-Fernandez, Beatriz ;
Dolores Sanchez-Nino, Maria .
NUTRIENTS, 2021, 13 (04)